The Cholangiocarcinoma Conference is the first of its kind solely focused on detailing current advances, critical challenges, and future directions of basic, translational, and clinical cholangiocarcinoma (CCA) research at Omni Rancho Las Palmas Resort & Spa 41000 Bob Hope Drive USA. It will bring together an international community of senior and early-career investigators to address important areas of current and evolving basic, translational, and clinical research focused on the critical challenges to significant improvements in CCA clinical management and patient survival outcomes. It also aims to recruit early career researchers and underrepresented scientists to the CCA research community and encourage networking with international CCA research consortiums and patient advocacy organizations.
The program is designed to provide a collegial and collaborative environment that supports the sharing of new ideas, fosters early career investigator development, and promotes scientific cross-talk between different disciplines.
Key topic areas that will be addressed include: 1) Challenges of inter- and intratumor heterogeneity; 2) Roles of the microbiome and tumor microenvironment in affecting disease progression, therapeutic resistance, and immunosurveillance; 3) Cellular origins, lineage, and genomic relationships between CCA and hepatocellular carcinoma; 4) Identification of novel and more effective biomarker signatures for early CCA detection and for monitoring prognosis and treatments; 5) Advances in "omics" for personalizing therapies; 7) Innovative preclinical modeling for CCA drug discovery; 7) Current and emerging trends in CCA personalized medicine; 8) New technologies and approaches for CCA therapies.